Monitoring peptide processing for MHC class I molecules in the endoplasmic reticulum

Current Opinion in Immunology

Volumn 26, Issue 1, 2014, Pages 123-127

  Shastri, Nilabh ^a   Nagarajan, Niranjana ^a   Lind, Kristin C ^a   Kanaseki, Takayuki ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPEPTIDASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEIN ERAAP; PROTEIN ERAP1; PROTEIN ERAP2; SYNTHETIC PEPTIDE; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; CD8+ T LYMPHOCYTE; ENDOPLASMIC RETICULUM; GENETIC ASSOCIATION; HUMAN; IMMUNE RESPONSE; IMMUNOSURVEILLANCE; LYMPHOCYTE SUBPOPULATION; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN POLYMORPHISM; PROTEIN PROCESSING; PROTEIN TARGETING; REVIEW;

AMINOPEPTIDASES; ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; ENDOPLASMIC RETICULUM; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MICE; MONITORING, IMMUNOLOGIC; PEPTIDE FRAGMENTS; SIGNAL TRANSDUCTION; STEM CELLS; SUBSTRATE SPECIFICITY;

EID: 84890047365     PISSN: 09527915     EISSN: 18790372     Source Type: Journal    
DOI: 10.1016/j.coi.2013.11.006     Document Type: Review

References (44)

1. Neefjes J., Jongsma M.L., Paul P., Bakke O. Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 2011, 11:823-836.
2. Blum J.S., Wearsch P.A., Cresswell P. Pathways of antigen processing. Annu Rev Immunol 2013, 31:443-473.
3. Hansen T.H., Bouvier M. MHC class I antigen presentation: learning from viral evasion strategies. Nat Rev Immunol 2009, 9:503-513.
4. Colbert J.D., Farfan-Arribas D.J., Rock K.L. Substrate-induced protein stabilization reveals a predominant contribution from mature proteins to peptides presented on MHC class I. J Immunol 2013.
5. Yewdell J.W. DRiPs solidify: progress in understanding endogenous MHC class I antigen processing. Trends Immunol 2011, 32:548-558.
6. Apcher S., Millot G., Daskalogianni C., Scherl A., Manoury B., Fahraeus R. Translation of pre-spliced RNAs in the nuclear compartment generates peptides for the MHC class I pathway. Proc Natl Acad Sci U S. A 2013, 110:17951-17956.
7. Starck S.R., Jiang V., Pavon-Eternod M., Prasad S., McCarthy B., Pan T., Shastri N. Leucine-tRNA initiates at CUG start codons for protein synthesis and presentation by MHC class I. Science 2012, 336:1719-1723.
8. Farfan-Arribas D.J., Stern L.J., Rock K.L. Using intein catalysis to probe the origin of major histocompatibility complex class I-presented peptides. Proc Natl Acad Sci U S A 2012, 109:16998-17003.
9. Shastri N., Cardinaud S., Schwab S.R., Serwold T., Kunisawa J. All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway. Immunol Rev 2005, 207:31-41.
10. Blanchard N., Shastri N. Coping with loss of perfection in the MHC class I peptide repertoire. Curr Opin Immunol 2008, 20:82-88.
11. Kanaseki T., Lind K.C., Escobar H., Nagarajan N., Reyes-Vargas E., Rudd B., Rockwood A.L., Van Kaer L., Sato N., Delgado J.C., et al. ERAAP and tapasin independently edit the amino and carboxyl termini of MHC class I peptides. J Immunol 2013, 191:1547-1555.
12. Wearsch P.A., Cresswell P. The quality control of MHC class I peptide loading. Curr Opin Cell Biol 2008, 20:624-631.
13. Cardinaud S., Starck S.R., Chandra P., Shastri N. The synthesis of truncated polypeptides for immune surveillance and viral evasion. PLoS ONE 2010, 5:e8692.
14. Tellam J., Smith C., Rist M., Webb N., Cooper L., Vuocolo T., Connolly G., Tscharke D.C., Devoy M.P., Khanna R. Regulation of protein translation through mRNA structure influences MHC class I loading and T cell recognition. Proc Natl Acad Sci U S A 2008, 105:9319-9324.
15. Tellam J.T., Lekieffre L., Zhong J., Lynn D.J., Khanna R. Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1. PLoS Pathog 2012, 8:e1003112.
16. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature 1995, 375:411-415.
17. Fruh K., Ahn K., Djaballah H., Sempe P., van Endert P.M., Tampe R., Peterson P.A., Yang Y. A viral inhibitor of peptide transporters for antigen presentation. Nature 1995, 375:415-418.
18. Hengel H., Koopmann J.O., Flohr T., Muranyi W., Goulmy E., Hämmerling G.J., Koszinowski U.H., Momburg F. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 1997, 6:623-632.
19. Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J.H.J., Ploegh H.L., Peterson P.A., Yang Y., Fruh K. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 1997, 6:613-621.
20. Elliott T., Townsend A., Cerundolo V. Antigen presentation: naturally processed peptides. Nature 1990, 348:195-197.
21. Serwold T., Gonzalez F., Kim J., Jacob R., Shastri N. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 2002, 419:480-483.
22. Saric T., Chang S.C., Hattori A., York I.A., Markant S., Rock K.L., Tsujimoto M., Goldberg A.L. An IFN-g-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat Immunol 2002, 3:1169-1176.
23. Hammer G.E., Gonzalez F., Champsaur M., Cado D., Shastri N. The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules. Nat Immunol 2006, 7:103-112.
24. Yan J., Parekh V.V., Mendez-Fernandez Y., Olivares-Villagomez D., Dragovic S., Hill T., Roopenian D.C., Joyce S., Van Kaer L. In vivo role of ER-associated peptidase activity in tailoring peptides for presentation by MHC class Ia and class Ib molecules. J Exp Med 2006, 203:647-659.
25. Firat E., Saveanu L., Aichele P., Staeheli P., Huai J., Gaedicke S., Nil A., Besin G., Kanzler B., van Endert P., et al. The role of endoplasmic reticulum-associated aminopeptidase 1 in immunity to infection and in cross-presentation. J Immunol 2007, 178:2241-2248.
26. York I.A., Brehm M.A., Zendzian S., Towne C.F., Rock K.L. Endoplasmic reticulum aminopeptidase 1 (ERAP1) trims MHC class I-presented peptides in vivo and plays an important role in immunodominance. Proc Natl Acad Sci U S A 2006, 103:9202-9207.
27. Evnouchidou I., Papakyriakou A., Stratikos E. A new role for Zn(II) aminopeptidases: antigenic peptide generation and destruction. Curr Pharm Des 2009, 15:3656-3670.
28. Zervoudi E., Papakyriakou A., Georgiadou D., Evnouchidou I., Gajda A., Poreba M., Salvesen G.S., Drag M., Hattori A., Swevers L., et al. Probing the S1 specificity pocket of the aminopeptidases that generate antigenic peptides. Biochem J 2011, 435:411-420.
29. Saveanu L., Carroll O., Lindo V., Del Val M., Lopez D., Lepelletier Y., Greer F., Schomburg L., Fruci D., Niedermann G., et al. Concerted peptide trimming by human ERAP1 and ERAP2 aminopeptidase complexes in the endoplasmic reticulum. Nat Immunol 2005, 6:689-697.
30. Chang S.C., Momburg F., Bhutani N., Goldberg A.L. The ER aminopeptidase, ERAP1, trims precursors to lengths of MHC class I peptides by a molecular ruler mechanism. Proc Natl Acad Sci U S A 2005, 102:17107-17112.
31. Nguyen T.T., Chang S.C., Evnouchidou I., York I.A., Zikos C., Rock K.L., Goldberg A.L., Stratikos E., Stern L.J. Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1. Nat Struct Mol Biol 2011, 18:604-613.
32. Birtley J.R., Saridakis E., Stratikos E., Mavridis I.M. The crystal structure of human endoplasmic reticulum aminopeptidase 2 reveals the atomic basis for distinct roles in antigen processing. Biochemistry 2012, 51:286-295.
33. Kochan G., Krojer T., Harvey D., Fischer R., Chen L., Vollmar M., von Delft F., Kavanagh K.L., Brown M.A., Bowness P., et al. Crystal structures of the endoplasmic reticulum aminopeptidase-1 (ERAP1) reveal the molecular basis for N-terminal peptide trimming. Proc Natl Acad Sci U S A 2011, 108:7745-7750.
34. Evnouchidou I., Kamal R.P., Seregin S.S., Goto Y., Tsujimoto M., Hattori A., Voulgari P.V., Drosos A.A., Amalfitano A., York I.A., et al. Cutting edge: coding single nucleotide polymorphisms of endoplasmic reticulum aminopeptidase 1 can affect antigenic Peptide generation in vitro by influencing basic enzymatic properties of the enzyme. J Immunol 2011, 186:1909-1913.
35. Hammer G.E., Gonzalez F., James E., Nolla H., Shastri N. In the absence of aminopeptidase ERAAP, MHC class I molecules present many unstable and highly immunogenic peptides. Nat Immunol 2007, 8:101-108.
36. Blanchard N., Kanaseki T., Escobar H., Delebecque F., Nagarajan N.A., Reyes-Vargas E., Crockett D.K., Raulet D.H., Delgado J.C., Shastri N. Endoplasmic reticulum aminopeptidase associated with antigen processing defines the composition and structure of MHC class I peptide repertoire in normal and virus-infected cells. J Immunol 2010, 184:3033-3042.
37. Kanaseki T., Blanchard N., Hammer G.E., Gonzalez F., Shastri N. ERAAP synergizes with MHC class I molecules to make the final cut in the antigenic peptide precursors in the endoplasmic reticulum. Immunity 2006, 25:795-806.
38. Burton P.R., Clayton D.G., Cardon L.R., Craddock N., Deloukas P., Duncanson A., Kwiatkowski D.P., McCarthy M.I., Ouwehand W.H., Samani N.J., et al. Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet 2007, 39:1329-1337.
39. Keidel S., Chen L., Pointon J., Wordsworth P. ERAP1 and ankylosing spondylitis. Curr Opin Immunol 2013, 25:97-102.
40. Strange A., Capon F., Spencer C.C., Knight J., Weale M.E., Allen M.H., Barton A., Band G., Bellenguez C., Bergboer J.G., et al. A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 2010, 42:985-990.
41. Fruci D., Giacomini P., Nicotra M.R., Forloni M., Fraioli R., Saveanu L., van Endert P., Natali P.G. Altered expression of endoplasmic reticulum aminopeptidases ERAP1 and ERAP2 in transformed non-lymphoid human tissues. J Cell Physiol 2008, 216:742-749.
42. Kim S., Lee S., Shin J., Kim Y., Evnouchidou I., Kim D., Kim Y.K., Kim Y.E., Ahn J.H., Riddell S.R., et al. Human cytomegalovirus microRNA miR-US4-1 inhibits CD8(+) T cell responses by targeting the aminopeptidase ERAP1. Nat Immunol 2011, 12:984-991.
43. Nagarajan N.A., Gonzalez F., Shastri N. Nonclassical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol 2012.
44. Cho H., Bediako Y., Xu H., Choi H.J., Wang C.R. Positive selecting cell type determines the phenotype of MHC class Ib-restricted CD8+ T cells. Proc Natl Acad Sci U S A 2011, 108:13241-13246.